Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility Medical Dialogues Bureau1 April 2020 7:14 AM GMTBengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S. FD...
Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 5:59 AM GMTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab Medical Dialogues Bureau10 March 2020 7:45 AM GMTBiocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection Medical Dialogues Bureau29 Feb 2020 6:05 AM GMTNew Delhi: Drug API maker, Biocon has informed that the U.S. Food and Drug Administration (FDA) conducted a Post-Approval and GMP inspection of Small...
Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations Medical Dialogues Bureau24 Feb 2020 6:41 AM GMTMalaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...
Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs Medical Dialogues Bureau21 Feb 2020 6:28 AM GMTThe meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
Primary healthcare can play key role in combating outbreaks like coronavirus: Biocon Chief Kiran Mazumdar-Shaw Medical Dialogues Bureau20 Feb 2020 8:47 AM GMTNew Delhi: Biocon Chairperson and MD Kiran Mazumdar-Shaw on Wednesday stressed the need for having an effective primary healthcare system saying it cou...
Minister inaugurates Syngene new RnD centre in Hyderabad Medical Dialogues Bureau18 Feb 2020 10:49 AM GMTThis is Syngene International Ltd.'s first operational research centre outside Bengaluru. When fully commissioned by the end of this year at an...
USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility MD bureau28 Jan 2020 8:54 AM GMTNew Delhi: Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of...
Biocon Biologics gets Rs 536 crore investment from True North Fund Farhat Nasim22 Jan 2020 7:39 AM GMTNew Delhi: Biocon recently announced that Biocon Biologics India has received the subscription money aggregating to Rs. 536.25 crore from Activ Pine LL...
Biocon Bengaluru facility clears USFDA inspection Farhat Nasim21 Jan 2020 7:30 AM GMT The US Food and Drug Administration (USFDA) conducted a pre-approval inspection of the oral solid dosage manufacturing facility of Biocon Pharma, a s...
Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour Medical Dialogues Bureau20 Jan 2020 6:30 AM GMT Kiran Mazumdar Shaw, Biocon founder and an Australian Global Alumni Ambassador, is also recognised for her sustained and significant contribution to ...
